Drug Information

Drug General Information
Drug ID
D0D5XX
Former ID
DIB020673
Drug Name
peptide 4
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529332], [531567]
Structure
Download
2D MOL
Formula
C20H36N8O6
InChI
InChI=1S/C20H36N8O6/c1-9(2)14(18(32)27-12(5)19(33)34)28-16(30)11(4)25-15(29)10(3)26-17(31)13(21)7-6-8-24-20(22)23/h9-10,12-14H,4,6-8,21H2,1-3,5H3,(H,25,29)(H,26,31)(H,27,32)(H,28,30)(H,33,34)(H4,22,23,24)/t10-,12-,13-,14-/m0/s1
InChIKey
VZQHRKZCAZCACO-PYJNHQTQSA-N
PubChem Compound ID
44450050
PubChem Substance ID
103565461, 160855839, 252166783
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [529332]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 529332Use of lantibiotic synthetases for the preparation of bioactive constrained peptides. Bioorg Med Chem Lett. 2008 May 15;18(10):3025-8.
Ref 531567Structure and function of tripeptidyl peptidase II, a giant cytosolic protease. Biochim Biophys Acta. 2012 Jan;1824(1):237-45.
Ref 529332Use of lantibiotic synthetases for the preparation of bioactive constrained peptides. Bioorg Med Chem Lett. 2008 May 15;18(10):3025-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.